Holista Colltech Limited
Holista Colltech Limited (HCT.AX) Stock Competitors & Peer Comparison
See (HCT.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Packaged Foods Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HCT.AX | A$0.07 | +32.69% | 18.9M | -3.25 | -A$0.02 | N/A |
| A2M.AX | A$7.12 | -3.26% | 5.3B | 29.12 | A$0.25 | +2.31% |
| BKL.AX | A$94.73 | +0.03% | 1.8B | 53.82 | A$1.76 | +1.26% |
| CBO.AX | A$3.77 | +1.34% | 1.8B | 37.20 | A$0.10 | +1.21% |
| BGA.AX | A$5.54 | -5.22% | 1.7B | 186.33 | A$0.03 | +2.33% |
| RIC.AX | A$2.83 | +1.07% | 1B | 14.00 | A$0.20 | +3.61% |
| SHV.AX | A$3.81 | -1.04% | 540M | 17.27 | A$0.22 | N/A |
| SM1.AX | A$0.37 | +0.00% | 223.2M | -2.18 | -A$0.17 | N/A |
| CLV.AX | A$0.99 | -1.50% | 159.5M | 19.10 | A$0.05 | +2.09% |
| BXN.AX | A$0.06 | -7.69% | 131.7M | -5.80 | -A$0.01 | N/A |
Stock Comparison
HCT.AX vs A2M.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, A2M.AX has a market cap of 5.3B. Regarding current trading prices, HCT.AX is priced at A$0.07, while A2M.AX trades at A$7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas A2M.AX's P/E ratio is 29.12. In terms of profitability, HCT.AX's ROE is -3.21%, compared to A2M.AX's ROE of +0.16%. Regarding short-term risk, HCT.AX is more volatile compared to A2M.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check A2M.AX's competition here
HCT.AX vs BKL.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, BKL.AX has a market cap of 1.8B. Regarding current trading prices, HCT.AX is priced at A$0.07, while BKL.AX trades at A$94.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas BKL.AX's P/E ratio is 53.82. In terms of profitability, HCT.AX's ROE is -3.21%, compared to BKL.AX's ROE of +0.08%. Regarding short-term risk, HCT.AX is more volatile compared to BKL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check BKL.AX's competition here
HCT.AX vs CBO.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, CBO.AX has a market cap of 1.8B. Regarding current trading prices, HCT.AX is priced at A$0.07, while CBO.AX trades at A$3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas CBO.AX's P/E ratio is 37.20. In terms of profitability, HCT.AX's ROE is -3.21%, compared to CBO.AX's ROE of +0.03%. Regarding short-term risk, HCT.AX is more volatile compared to CBO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check CBO.AX's competition here
HCT.AX vs BGA.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, BGA.AX has a market cap of 1.7B. Regarding current trading prices, HCT.AX is priced at A$0.07, while BGA.AX trades at A$5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas BGA.AX's P/E ratio is 186.33. In terms of profitability, HCT.AX's ROE is -3.21%, compared to BGA.AX's ROE of +0.01%. Regarding short-term risk, HCT.AX is less volatile compared to BGA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for HCT.AX.Check BGA.AX's competition here
HCT.AX vs RIC.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, RIC.AX has a market cap of 1B. Regarding current trading prices, HCT.AX is priced at A$0.07, while RIC.AX trades at A$2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas RIC.AX's P/E ratio is 14.00. In terms of profitability, HCT.AX's ROE is -3.21%, compared to RIC.AX's ROE of +0.15%. Regarding short-term risk, HCT.AX is more volatile compared to RIC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check RIC.AX's competition here
HCT.AX vs SHV.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, SHV.AX has a market cap of 540M. Regarding current trading prices, HCT.AX is priced at A$0.07, while SHV.AX trades at A$3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas SHV.AX's P/E ratio is 17.27. In terms of profitability, HCT.AX's ROE is -3.21%, compared to SHV.AX's ROE of +0.06%. Regarding short-term risk, HCT.AX is more volatile compared to SHV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check SHV.AX's competition here
HCT.AX vs SM1.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, SM1.AX has a market cap of 223.2M. Regarding current trading prices, HCT.AX is priced at A$0.07, while SM1.AX trades at A$0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas SM1.AX's P/E ratio is -2.18. In terms of profitability, HCT.AX's ROE is -3.21%, compared to SM1.AX's ROE of -0.17%. Regarding short-term risk, HCT.AX is more volatile compared to SM1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check SM1.AX's competition here
HCT.AX vs CLV.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, CLV.AX has a market cap of 159.5M. Regarding current trading prices, HCT.AX is priced at A$0.07, while CLV.AX trades at A$0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas CLV.AX's P/E ratio is 19.10. In terms of profitability, HCT.AX's ROE is -3.21%, compared to CLV.AX's ROE of +0.12%. Regarding short-term risk, HCT.AX is more volatile compared to CLV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check CLV.AX's competition here
HCT.AX vs BXN.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, BXN.AX has a market cap of 131.7M. Regarding current trading prices, HCT.AX is priced at A$0.07, while BXN.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas BXN.AX's P/E ratio is -5.80. In terms of profitability, HCT.AX's ROE is -3.21%, compared to BXN.AX's ROE of +0.56%. Regarding short-term risk, HCT.AX is less volatile compared to BXN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for HCT.AX.Check BXN.AX's competition here
HCT.AX vs BUB.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, BUB.AX has a market cap of 98.4M. Regarding current trading prices, HCT.AX is priced at A$0.07, while BUB.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas BUB.AX's P/E ratio is 11.00. In terms of profitability, HCT.AX's ROE is -3.21%, compared to BUB.AX's ROE of +0.09%. Regarding short-term risk, HCT.AX is more volatile compared to BUB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check BUB.AX's competition here
HCT.AX vs SPG.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, SPG.AX has a market cap of 67.7M. Regarding current trading prices, HCT.AX is priced at A$0.07, while SPG.AX trades at A$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas SPG.AX's P/E ratio is -1.84. In terms of profitability, HCT.AX's ROE is -3.21%, compared to SPG.AX's ROE of -0.63%. Regarding short-term risk, HCT.AX is less volatile compared to SPG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for HCT.AX.Check SPG.AX's competition here
HCT.AX vs NOU.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, NOU.AX has a market cap of 31.9M. Regarding current trading prices, HCT.AX is priced at A$0.07, while NOU.AX trades at A$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas NOU.AX's P/E ratio is -0.35. In terms of profitability, HCT.AX's ROE is -3.21%, compared to NOU.AX's ROE of +0.20%. Regarding short-term risk, HCT.AX is more volatile compared to NOU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check NOU.AX's competition here
HCT.AX vs MBH.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, MBH.AX has a market cap of 30.2M. Regarding current trading prices, HCT.AX is priced at A$0.07, while MBH.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas MBH.AX's P/E ratio is -2.08. In terms of profitability, HCT.AX's ROE is -3.21%, compared to MBH.AX's ROE of -0.54%. Regarding short-term risk, HCT.AX is more volatile compared to MBH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check MBH.AX's competition here
HCT.AX vs FOD.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, FOD.AX has a market cap of 23.7M. Regarding current trading prices, HCT.AX is priced at A$0.07, while FOD.AX trades at A$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas FOD.AX's P/E ratio is -10.00. In terms of profitability, HCT.AX's ROE is -3.21%, compared to FOD.AX's ROE of -0.22%. Regarding short-term risk, HCT.AX is less volatile compared to FOD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for HCT.AX.Check FOD.AX's competition here
HCT.AX vs NUC.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, NUC.AX has a market cap of 22M. Regarding current trading prices, HCT.AX is priced at A$0.07, while NUC.AX trades at A$0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas NUC.AX's P/E ratio is -4.67. In terms of profitability, HCT.AX's ROE is -3.21%, compared to NUC.AX's ROE of -0.42%. Regarding short-term risk, HCT.AX is more volatile compared to NUC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check NUC.AX's competition here
HCT.AX vs AHF.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, AHF.AX has a market cap of 17.5M. Regarding current trading prices, HCT.AX is priced at A$0.07, while AHF.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas AHF.AX's P/E ratio is -2.30. In terms of profitability, HCT.AX's ROE is -3.21%, compared to AHF.AX's ROE of -0.19%. Regarding short-term risk, HCT.AX is more volatile compared to AHF.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check AHF.AX's competition here
HCT.AX vs JAT.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, JAT.AX has a market cap of 12.1M. Regarding current trading prices, HCT.AX is priced at A$0.07, while JAT.AX trades at A$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas JAT.AX's P/E ratio is -7.25. In terms of profitability, HCT.AX's ROE is -3.21%, compared to JAT.AX's ROE of -0.27%. Regarding short-term risk, HCT.AX is more volatile compared to JAT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check JAT.AX's competition here
HCT.AX vs OMG.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, OMG.AX has a market cap of 7.6M. Regarding current trading prices, HCT.AX is priced at A$0.07, while OMG.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas OMG.AX's P/E ratio is N/A. In terms of profitability, HCT.AX's ROE is -3.21%, compared to OMG.AX's ROE of -0.35%. Regarding short-term risk, HCT.AX is more volatile compared to OMG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check OMG.AX's competition here
HCT.AX vs EVE.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, EVE.AX has a market cap of 7M. Regarding current trading prices, HCT.AX is priced at A$0.07, while EVE.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas EVE.AX's P/E ratio is -3.10. In terms of profitability, HCT.AX's ROE is -3.21%, compared to EVE.AX's ROE of -0.44%. Regarding short-term risk, HCT.AX is more volatile compared to EVE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check EVE.AX's competition here
HCT.AX vs CCO.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, CCO.AX has a market cap of 6.8M. Regarding current trading prices, HCT.AX is priced at A$0.07, while CCO.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas CCO.AX's P/E ratio is -0.25. In terms of profitability, HCT.AX's ROE is -3.21%, compared to CCO.AX's ROE of -3.23%. Regarding short-term risk, HCT.AX is less volatile compared to CCO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for HCT.AX.Check CCO.AX's competition here
HCT.AX vs BFC.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, BFC.AX has a market cap of 6M. Regarding current trading prices, HCT.AX is priced at A$0.07, while BFC.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas BFC.AX's P/E ratio is -0.10. In terms of profitability, HCT.AX's ROE is -3.21%, compared to BFC.AX's ROE of -1.11%. Regarding short-term risk, HCT.AX is less volatile compared to BFC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for HCT.AX.Check BFC.AX's competition here
HCT.AX vs OJC.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, OJC.AX has a market cap of 5.3M. Regarding current trading prices, HCT.AX is priced at A$0.07, while OJC.AX trades at A$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas OJC.AX's P/E ratio is -0.78. In terms of profitability, HCT.AX's ROE is -3.21%, compared to OJC.AX's ROE of -0.63%. Regarding short-term risk, HCT.AX is more volatile compared to OJC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check OJC.AX's competition here
HCT.AX vs HPP.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, HPP.AX has a market cap of 5.2M. Regarding current trading prices, HCT.AX is priced at A$0.07, while HPP.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas HPP.AX's P/E ratio is -0.84. In terms of profitability, HCT.AX's ROE is -3.21%, compared to HPP.AX's ROE of -0.09%. Regarding short-term risk, HCT.AX is more volatile compared to HPP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check HPP.AX's competition here
HCT.AX vs WNX.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, WNX.AX has a market cap of 5.1M. Regarding current trading prices, HCT.AX is priced at A$0.07, while WNX.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas WNX.AX's P/E ratio is -0.23. In terms of profitability, HCT.AX's ROE is -3.21%, compared to WNX.AX's ROE of -0.93%. Regarding short-term risk, HCT.AX is less volatile compared to WNX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for HCT.AX.Check WNX.AX's competition here
HCT.AX vs FFF.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, FFF.AX has a market cap of 4.3M. Regarding current trading prices, HCT.AX is priced at A$0.07, while FFF.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas FFF.AX's P/E ratio is -0.60. In terms of profitability, HCT.AX's ROE is -3.21%, compared to FFF.AX's ROE of -0.48%. Regarding short-term risk, HCT.AX is more volatile compared to FFF.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check FFF.AX's competition here
HCT.AX vs PFT.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, PFT.AX has a market cap of 3.4M. Regarding current trading prices, HCT.AX is priced at A$0.07, while PFT.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas PFT.AX's P/E ratio is -0.83. In terms of profitability, HCT.AX's ROE is -3.21%, compared to PFT.AX's ROE of -1.86%. Regarding short-term risk, HCT.AX is more volatile compared to PFT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check PFT.AX's competition here
HCT.AX vs CSF.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, CSF.AX has a market cap of 3.2M. Regarding current trading prices, HCT.AX is priced at A$0.07, while CSF.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas CSF.AX's P/E ratio is -1.00. In terms of profitability, HCT.AX's ROE is -3.21%, compared to CSF.AX's ROE of -1.06%. Regarding short-term risk, HCT.AX is more volatile compared to CSF.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check CSF.AX's competition here
HCT.AX vs HLF.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, HLF.AX has a market cap of 2.8M. Regarding current trading prices, HCT.AX is priced at A$0.07, while HLF.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas HLF.AX's P/E ratio is -0.06. In terms of profitability, HCT.AX's ROE is -3.21%, compared to HLF.AX's ROE of -1.57%. Regarding short-term risk, HCT.AX is more volatile compared to HLF.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check HLF.AX's competition here
HCT.AX vs NGS.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, NGS.AX has a market cap of 2.6M. Regarding current trading prices, HCT.AX is priced at A$0.07, while NGS.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas NGS.AX's P/E ratio is -1.60. In terms of profitability, HCT.AX's ROE is -3.21%, compared to NGS.AX's ROE of +2.27%. Regarding short-term risk, HCT.AX is more volatile compared to NGS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check NGS.AX's competition here
HCT.AX vs HVM.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, HVM.AX has a market cap of 2M. Regarding current trading prices, HCT.AX is priced at A$0.07, while HVM.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas HVM.AX's P/E ratio is -0.43. In terms of profitability, HCT.AX's ROE is -3.21%, compared to HVM.AX's ROE of -0.54%. Regarding short-term risk, HCT.AX is more volatile compared to HVM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check HVM.AX's competition here
HCT.AX vs TFL.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, TFL.AX has a market cap of 1.9M. Regarding current trading prices, HCT.AX is priced at A$0.07, while TFL.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas TFL.AX's P/E ratio is -0.25. In terms of profitability, HCT.AX's ROE is -3.21%, compared to TFL.AX's ROE of -1.68%. Regarding short-term risk, HCT.AX is more volatile compared to TFL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check TFL.AX's competition here
HCT.AX vs FIJ.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, FIJ.AX has a market cap of 1.2M. Regarding current trading prices, HCT.AX is priced at A$0.07, while FIJ.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas FIJ.AX's P/E ratio is -0.15. In terms of profitability, HCT.AX's ROE is -3.21%, compared to FIJ.AX's ROE of -2.13%. Regarding short-term risk, HCT.AX is more volatile compared to FIJ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check FIJ.AX's competition here
HCT.AX vs MBX.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, MBX.AX has a market cap of 556.7K. Regarding current trading prices, HCT.AX is priced at A$0.07, while MBX.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas MBX.AX's P/E ratio is -0.01. In terms of profitability, HCT.AX's ROE is -3.21%, compared to MBX.AX's ROE of +0.25%. Regarding short-term risk, HCT.AX is more volatile compared to MBX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check MBX.AX's competition here
HCT.AX vs NZS.AX Comparison April 2026
HCT.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCT.AX stands at 18.9M. In comparison, NZS.AX has a market cap of 333.4K. Regarding current trading prices, HCT.AX is priced at A$0.07, while NZS.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCT.AX currently has a P/E ratio of -3.25, whereas NZS.AX's P/E ratio is -0.10. In terms of profitability, HCT.AX's ROE is -3.21%, compared to NZS.AX's ROE of -0.28%. Regarding short-term risk, HCT.AX is more volatile compared to NZS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HCT.AX.Check NZS.AX's competition here